With this model, we are able to investigate the unknown intracellular mechanisms of TSP1 via receptor CD47 and generate insight to help address the problem of systemic hypertension elicited by anti-angiogenic drugs, novel contributions of our work. This evidence concerns the gene CD47 and Hypertension.